A GATE Monte Carlo framework for dosimetric evaluation in mammography in an Algerian hospital.

A framework has been developed for dosimetric evaluation in mammography, using the GATE Monte Carlo (MC) platform, to simulate a MAMMOMAT 3000 Nova mammograph (Siemens) available at the University Hospital Center "1st November 1954" of Oran (EHU Oran 1er Novembre, 1954), Algeria. Calculated quantities such half-value layer (HVL), Entrance Surface Dose (ESD) and Mean Glandular Dose (MGD) have been compared to experimental data in order to validate the modeling of mammography examinations. Results are consistent with previous studies and show a good agreement between measurements and Monte Carlo calculations. By varying the tube voltage from 25 to 35 kV, we have estimated an increasing of a factor of 2.4 in ESD, and a factor of 2.75 for the MGD in a breast phantom. Furthermore, the current intensity of 100 mAs used for a beam quality combination (Mo/Mo) Anode/filter was found suitable for the tube voltages of 25-29 keV since the MGD does not exceed the limits set by the different quality insurance protocols. This GATE dose calculation framework thus provides a very useful tool for the optimization of mammography examinations at Oran hospital by allowing a better estimation of the dose delivered to patients according to the parameters of the examination.

Monte-Carlo dosimetry for intraoperative radiotherapy using a low energy x-ray source.

UNLABELLED: Intraoperative radiotherapy (IORT) is continuously gaining ground in cancer treatment. However, there is currently no planning system associated with these devices, which precludes patient-specific dose delivery optimization. The objective of this study was the development and validation of a Monte Carlo simulation (MCS)-based dosimetry platform using the Intrabeam™ system. METHODS: After surgical resection of the tumor this system delivers a single dose fraction at the surface of an applicator irradiating the tumor bed through a 50 kV x-ray beam. The GATE MCS platform was used in this study combining the phase space obtained by modeling the x-ray source and the detailed modeling of the additional parts of the Intrabeam™ system. The model was validated by comparing simulated versus experimental measurements of depth dose curves (DDC) and isotropy. A clinical validation study was also carried out using patient computed tomography images. RESULTS: The mean deviation between measured and simulated DDC was 2.9% ± 4.4% and 5.9% ± 5.7% for the bare needle and the use of applicators, respectively. A good agreement with experimental measurements was also found in terms of dose isotropy with a maximum difference of 2.04% for the 40 mm diameter applicator. A patient study revealed a mean absolute deviation of 0.06 Gy between simulated and thermoluminescent dosimeters (TLD) measured skin doses. CONCLUSION: This study shows the potential of using the GATE MCS platform to model three-dimensional dose distributions of the Intrabeam™ system for use in IORT.